The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

If the market experiences corrections, Vikas Gupta sees attractive opportunities in sectors like large-cap banking, power, housing finance, logistics, and infrastructure EPCs.

Chandigarh: The internal security wing of the Punjab Police busted 12 terror modules with the arrest of 66 terrorists after ...

The year in politics was largely defined by quotes from Donald Trump, Joe Biden, Kamala Harris, Robert F. Kennedy Jr., Tim Walz, Elon Musk, and more.

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK ...